Skip to main content

Closed

TVTX: Travere Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+60.6% / yr

Operating margin-10.6%

ROIC-13.1%

Financially safe

Stretched

Debt / equity3.32×

Interest coverage-5.6×

Current ratio3.13×

Travere Therapeutics, Inc.

TVTXNASDAQ Global Market·USD·Closed

Travere Therapeutics, Inc.

TVTXNASDAQ·USD·Closed

$55.89

−2.43%

$55.89

−$1.39 (2.43%)

52W Range

91thpctl

Volume

0.72×avg

Mkt Cap

5.20BUSD

P/E

-114.1TTM

Div Yield

–ann

52W Range

91thpctl

Volume

0.72×avg

Market Cap

5.20BUSD

P/E Ratio

-114.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings